Bluepharma - Industria Farmaceuticasa

Bluepharma - Industria Farmaceuticasa is a company in Coimbra, Portugal that has taken part in 6 EU-funded projects since 2015, receiving €1.2M in EU funding.

EU funding received€1.2M
EU projects6
As coordinator0
Running now3
First EU project2015
Latest project2026
CountryPortugal
EU registration (PIC)952690545
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bluepharma - Industria Farmaceuticasa's own share of each project, not the project's full budget.

  • Horizon 2020€824k · 2 projects
  • Horizon Europe€410k · 3 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • OMNIAPartner

    OMNIA: Orchestrating Multi-Omic Nanomedicine Insights with AI and Spatial Biology–Driven Innovation and Training for Hard-to-Treat Cancers

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €60ktheir share
  • GeneHPartner

    Excellence Hub for Advancing Innovation in Gene Therapy

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €350ktheir share
  • EC2UAssociated partner

    European Campus of City-Universities

    Erasmus+ (ERASMUS+) · 2023–2027 · Project on the EU portal ↗

  • OncoNanoRAssociated partner

    Engineering the immunosuppressive microenvironment in mesothelioma with targeted LipidNanoParticles encapsulating self-amplifying RNA

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

  • FOLSMARTPartner

    Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €344ktheir share
  • GLORIAPartner

    Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €480ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • catalysis
  • gene therapy
  • immunotherapy
  • nano-materials
  • nanomedicine
  • oncology
  • pharmacokinetics
  • public health
  • rheumatology
  • toxicology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime